{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:38:56Z","timestamp":1760524736865,"version":"3.41.2"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Locomotion improvement without serious complications is the main goal of treatment for feline aortic thromboembolism (FATE). We aimed to describe the survival and functional recovery of cardiogenic FATE treated with tissue plasminogen activator (rtPA) continuous rate infusion (CRI) and\/or pentoxifylline (PTX) and\/ or cyproheptadine (CYP), and to identify non-survivor characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective, bicentric case series. Inclusion criteria were cardiogenic FATE cats receiving any of the medications described. Proportions of locomotion recovery, survival to discharge, reperfusion injury (RI) and acute kidney injury (AKI) were described. Admission and outcome characteristics were compared between survivors and non-survivors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nine cats were identified, 8\/9 (88.9%) with bilateral FATE. Median age was 8.2\u202fyears (5.3\u201312.5). Median weight was 5.3\u202fkg (4.1\u20137.1). Admission rectal temperature, affected limb lactate, creatinine and potassium were 36.9\u00b0C (35.4\u201338.8), 14.2\u202fmmol\/L (7.1\u201318.8), 114.9 umol\/L (53\u2013185.6) and 3.7\u202fmmol\/L (3.5\u201344.), respectively. No significant differences were found between survivors and non-survivors for relevant admission characteristics. Seven (77.8%) cats received tPA-CRI, 7\/9 (77.8%) cats received pentoxifylline and 5\/9 (55.6%) cats received cyproheptadine. Three (33.3%) cats received monotherapy (two rtPA-CRI, one PTX), 2\/9 (22.2%) cats received dual therapy (one rtPA-CRI\/PTX, one PTX\/ CYP) and 4\/9 (44.4%) cats received triple therapy. All study cats (100%) had an improvement in locomotion, and 4\/9 (44.4%) survived to discharge. Reperfusion injury and AKI were documented in 3\/9 (33.3%) and 4\/9 (44.4%) of cats, respectively. Non-survivors had a greater proportion of AKI than survivors (4\/5 (80%) and 0\/4 (0%), respectively). No other outcome characteristics were different between survivors and non-survivors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>rtPA CRI, PTX and\/or CYP could be considered for treatment of FATE.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fvets.2025.1512649","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:24:51Z","timestamp":1747056291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of alteplase continuous rate infusion, pentoxifylline, and cyproheptadine in association or not, in acute feline aortic thromboembolism: a study of nine cats"],"prefix":"10.3389","volume":"12","author":[{"given":"Christopher C.","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Guillaumin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/jvim.12249","article-title":"Arterial thromboembolism in 250 cats in general practice: 2004\u20132012","volume":"28","author":"Borgeat","year":"2014","journal-title":"J Vet Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1939-1676.2003.tb01326.x","article-title":"Arterial thromboembolism in cats: acute crisis in 127 cases (1992\u20132001) and long-term management with low-dose aspirin in 24 cases","volume":"17","author":"Smith","year":"2003","journal-title":"J Vet Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0195-5616(88)50008-6","article-title":"Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator","volume":"18","author":"Pion","year":"1988","journal-title":"Vet Clin North Am Small Anim Pract"},{"article-title":"Multicentric aortic thromboembolism retrospective study in 158 cats: the maters study","year":"2022","author":"Cambournac","key":"ref4"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/jfms.1999.0049","article-title":"Feline distal aortic thromboembolism: a review of 44 cases (1990\u20131998)","volume":"1","author":"Schoeman","year":"1999","journal-title":"J Feline Med Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/vec.12795","article-title":"Consensus on the rational use of Antithrombotics in veterinary critical care (CURATIVE): domain 3-defining antithrombotic protocols","volume":"29","author":"Blais","year":"2019","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.1016\/j.jvc.2015.10.004","article-title":"Secondary prevention of cardiogenic arterial thromboembolism in the CAT: the double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT)","volume":"17","author":"Hogan","year":"2015","journal-title":"J Vet Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1098612x211013736","article-title":"Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease","volume":"24","author":"Lo","year":"2022","journal-title":"J Feline Med Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/vec.13227","article-title":"2022 update of the consensus on the rational use of Antithrombotics and Thrombolytics in veterinary critical care (CURATIVE) domain 6: defining rational use of thrombolytics","volume":"32","author":"Sharp","year":"2022","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1517\/17425255.2012.652615","article-title":"Pharmacokinetics of alteplase in the treatment of ischaemic stroke","volume":"8","author":"Acheampong","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1177\/1098612x221135105","article-title":"Bilateral lysis of aortic saddle thrombus with early tissue plasminogen activator (BLASTT): a prospective, randomized, placebo-controlled study in feline acute aortic thromboembolism","volume":"24","author":"Guillaumin","year":"2022","journal-title":"J Feline Med Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1098612x18778157","article-title":"Thrombolysis with tissue plasminogen activator (TPA) in feline acute aortic thromboembolism: a retrospective study of 16 cases","volume":"21","author":"Guillaumin","year":"2019","journal-title":"J Feline Med Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.040073","article-title":"Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030","volume":"54","author":"Pu","year":"2023","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1161\/STROKEAHA.109.552547","article-title":"Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke","volume":"40","author":"Lansberg","year":"2009","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1017\/s1047951119003093","article-title":"Spontaneous aortic thrombosis in neonates: a case report and review of literature","volume":"30","author":"Mulcaire-Jones","year":"2020","journal-title":"Cardiol Young"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0022-3476(05)82170-5","article-title":"Tissue plasminogen activator for the treatment of thromboembolism in infants and children","volume":"118","author":"Levy","year":"1991","journal-title":"J Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0030-1249662","article-title":"Neonatal aortic thrombosis: a comprehensive review","volume":"222","author":"Nagel","year":"2010","journal-title":"Klin Padiatr"},{"article-title":"Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in feline aortic thromboembolism: clinical and experimental data","year":"1987","author":"Pion","key":"ref19"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00000542-200106000-00030","article-title":"Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury","volume":"94","author":"Collard","year":"2001","journal-title":"Anesthesiology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1748-5827.1971.tb06212.x","article-title":"An investigation into the relationship of an aortic embolus to posterior paralysis in the cat","volume":"12","author":"Butler","year":"1971","journal-title":"J Small Anim Pract"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s12325-017-0547-2","article-title":"Repurposing Pentoxifylline for the treatment of fibrosis: an overview","volume":"34","author":"Wen","year":"2017","journal-title":"Adv Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2165\/00002512-199507060-00007","article-title":"Pentoxifylline (Oxpentifylline)","volume":"7","author":"Frampton","year":"1995","journal-title":"Drugs Aging"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/jcpt.13565","article-title":"Pentoxifylline in the treatment of neonatal vasospasm and thromboembolism: an observational case series study","volume":"47","author":"Bayraktar","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-3565(25)29907-4","article-title":"Influence of various substances which induce and inhibit aggregation on the uptake of deoxyglucose by human blood platelets","volume":"190","author":"Gaut","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1748-5827.1977.tb05878.x","article-title":"Five-hydroxytryptamine antagonists and feline aortic embolism","volume":"18","author":"Olmstead","year":"1977","journal-title":"J Small Anim Pract"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jvc.2019.04.003","article-title":"Left atrial size and volume in cats with primary cardiomyopathy with and without congestive heart failure","volume":"24","author":"Duler","year":"2019","journal-title":"J Vet Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/vr.c6234","article-title":"Prognosis of acute kidney injury in dogs using RIFLE (risk, injury, failure, loss and end-stage renal failure)-like criteria","volume":"168","author":"Lee","year":"2011","journal-title":"Vet Rec"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1476-4431.2011.00689.x","article-title":"Characterization of acute kidney injury in hospitalized dogs and evaluation of a veterinary acute kidney injury staging system","volume":"21","author":"Thoen","year":"2011","journal-title":"J Vet Emerg Crit Care"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"106068","DOI":"10.1016\/j.tvjl.2024.106068","article-title":"International renal interest society best practice consensus guidelines for the diagnosis and management of acute kidney injury in cats and dogs","volume":"305","author":"Segev","year":"2024","journal-title":"Vet J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e17254","DOI":"10.1111\/jvim.17254","article-title":"Frequency and progression of azotemia during acute and chronic treatment of congestive heart failure in cats","volume":"39","author":"Rogg","year":"2025","journal-title":"J Vet Intern Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4314\/ovj.v10i3.13","article-title":"Feline aortic thromboembolism: presentation, diagnosis, and treatment outcomes of 15 cats","volume":"10","author":"Hassan","year":"2020","journal-title":"Open Vet J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1476-4431.2000.tb00010.x","article-title":"Retrospective study of streptokinase administration in 46 cats with arterial thromboembolism","volume":"10","author":"Moore","year":"2000","journal-title":"J Vet Emerg Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jfms.2009.08.001","article-title":"Prospective evaluation of tissue plasminogen activator in 11 cats with arterial thromboembolism","volume":"12","author":"Welch","year":"2010","journal-title":"J Feline Med Surg"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1097\/ccm.0000000000004133","article-title":"Relative hyperglycemia is an independent determinant of in-hospital mortality in patients with critical illness","volume":"48","author":"Lee","year":"2020","journal-title":"Crit Care Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1939-1676.2007.tb03051.x","article-title":"Incidence and clinical relevance of hyperglycemia in critically ill dogs","volume":"21","author":"Torre","year":"2007","journal-title":"J Vet Intern Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1476-4431.2009.00435.x","article-title":"The prevalence and significance of hyperglycemia in hospitalized cats","volume":"19","author":"Ray","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"ref38","first-page":"295","article-title":"Therapy for feline aortic thromboembolism","volume-title":"Current veterinary therapy X: Small animal practice","author":"Pion","year":"1989"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00003246-199602000-00014","article-title":"Analysis of responses to pentoxifylline in the pulmonary vascular bed of the cat","volume":"24","author":"Kaye","year":"1996","journal-title":"Crit Care Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-510X(95)00153-S","article-title":"Pentoxifylline ameliorates postischemic delayed hypoperfusion of the cerebral cortex following cardiac arrest in cats","volume":"132","author":"Tanahashi","year":"1995","journal-title":"J Neurol Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1472-8206.2001.00007","article-title":"The effect of pentoxifylline on intestinal ischemia\/reperfusion injury","volume":"15","author":"Sener","year":"2001","journal-title":"Fundam Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0022-3468(97)90648-5","article-title":"Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury","volume":"32","author":"Sava\u015f","year":"1997","journal-title":"J Pediatr Surg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.jphs.2021.03.011","article-title":"The role of pentoxifylline in renal ischemic reperfusion cell injury and inflammatory reaction","volume":"5","author":"Doustar","year":"2011","journal-title":"Adv Environ Biol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-6576.1982.tb01722","article-title":"Pentoxifylline in regional cerebral ischemia in cats","volume":"26","author":"Steen","year":"1982","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1161\/01.cir.96.7.2280","article-title":"Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation","volume":"96","author":"Pakala","year":"1997","journal-title":"Circulation"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0735-1097(91)90945-6","article-title":"Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury","volume":"17","author":"Willerson","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/JCN.0b013e3182076a81","article-title":"The role of serotonin in depression and clotting in the coronary artery disease population","volume":"26","author":"Sanner","year":"2011","journal-title":"J Cardiovasc Nurs"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"920","DOI":"10.5555\/uri:pii:0039606072901948","article-title":"Intravenous cyproheptadine hydrochloride in the treatment of pulmonary embolism: an experimental study","volume":"72","author":"Nemir","year":"1972","journal-title":"Surgery"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s13760-020-01487-z","article-title":"Cyproheptadine in the treatment of reversible cerebral vasoconstriction syndrome","volume":"121","author":"Chima","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/BF03029752","article-title":"Effect of encainide, ODE, MODE, and flecainide on ADP\/5-HT induced platelet aggregation and in the anesthetized dog coronary artery stenosis-occlusion model of intravascular thrombosis","volume":"5","author":"Fleming","year":"1991","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijcard.2019.04.083","article-title":"Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry","volume":"291","author":"Murgier","year":"2019","journal-title":"Int J Cardiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jvsv.2020.11.005","article-title":"Risk factors for acute kidney injury after pharmacomechanical thrombolysis for acute deep vein thrombosis","volume":"9","author":"Salem","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0185589","DOI":"10.1371\/journal.pone.0185589","article-title":"The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis","volume":"12","author":"Gadalean","year":"2017","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1476-4431.2005.00155.x","article-title":"Retrospective evaluation of Urokinase use in cats with arterial thromboembolism (abstract)","volume":"15","author":"Whelan","year":"2005","journal-title":"J Vet Emerg Crit Care"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.2460\/javma.2004.225.1406","article-title":"Antiplatelet effects and pharmacodynamics of clopidogrel in cats","volume":"225","author":"Hogan","year":"2004","journal-title":"J Am Vet Med Assoc"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0049-3848(98)00114-5","article-title":"Modulation of vasoconstriction by Clopidogrel and Ticlopidine","volume":"92","author":"Yang","year":"1998","journal-title":"Thromb Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.avsg.2022.04.040","article-title":"Mechanisms and interventions on acute lower limb ischemia\/reperfusion injury: a review and insights from cell to clinical investigations","volume":"86","author":"Apichartpiyakul","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"ref58","first-page":"1","article-title":"Ischemia-reperfusion injury","volume":"10","author":"Conner","year":"2008","journal-title":"Stand Care Emerg Crit Care Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0741-5214(89)90081-5","article-title":"Avoiding reperfusion injury after limb revascularization: experimental observations and recommendations for clinical application","volume":"9","author":"Beyersdorf","year":"1989","journal-title":"J Vasc Surg"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/tgh.2019.08.12","article-title":"Postreperfusion syndrome, hyperkalemia and machine perfusion in liver transplantation. Translational","volume":"4","author":"Patrono","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"ref61","first-page":"S41","article-title":"Ancillary treatments with Thrombolytics or medications aimed at improving functional recovery or both in acute feline aortic thromboembolism","author":"Ray","year":"2024"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1512649\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:24:52Z","timestamp":1747056292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1512649\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":61,"alternative-id":["10.3389\/fvets.2025.1512649"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1512649","relation":{},"ISSN":["2297-1769"],"issn-type":[{"type":"electronic","value":"2297-1769"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"article-number":"1512649"}}